G-Pola-ZLP in Diffuse Large B-Cell Lymphoma

Sponsor
Navy General Hospital, Beijing
Study ID
NCT06665217
Phase
PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
14 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The goal of this phase 2 trial is to test the safety and efficacy of G-Pola-ZLP as induction therapy in patients with DLBCL.

Key Dates

Start date
Sep 24, 2025
Status verified
Aug 2025
Primary completion
Jan 31, 2029
Completion
Jan 31, 2030

Study Design

Enrollment
80 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Induction Therapy
    Patients were treated by G-Pola-ZLP as Induction Therapy

Primary Outcome Measure

Overall Response Rate (ORR) [ Time Frame: 1 year ]

Central Contacts

Related Studies